Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x100px
Organisation › Details

Sterna Biologicals (Genova) (Group)

Sterna biologicals GmbH & Co. KG is an innovative clinical-stage immunology company developing novel treatments for chronic inflammatory diseases such as asthma, chronic obstructive pulmonary disease (COPD), atopic dermatitis, and ulcerative colitis. By targeting transcription factors that play a central role in regulating Th1- and Th2-driven inflammatory mechanisms, the Company's proprietary DNAzyme-based drug candidates can intervene with key inflammatory processes to address related diseases more effectively. Sterna currently has four programs in phase 2 development. *

 

Period Start 2012-12-07 existent
Product Industry BIOTECH
Persons Person Pangratz, Christian M. (Atriva Therapeutics 202301– CEO before Sterna Biologicals + Secarna + Vectura + Sykepharma)
  Person 2 Renz, Jonas (Secarna + Genova + Sterna Biologicals 201604 Managing Director)
     
Region Region Marburg
  Country Germany
  Street 7 Bismarckstr.
  City 35037 Marburg
  Tel +49-6421-9830050
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Sterna Biologicals GmbH & Co. KG. (5/26/20). "Press Release: Sterna Biologicals Secures EUR 12.0 Million (approx. USD 13.0 Million) in Private Placement". Marburg.
     
   
Record changed: 2023-12-30

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Sterna Biologicals (Genova) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top